首页> 外国专利> COMPOSITION FOR REGULATING EXPRESSION OF PROX1 OR EXPRESSION OF TELOMERASE REVERSE TRANSCRIPTASE COMPRISING ACTIVITY REGULATOR OR METHOD FOR SCREENING TELOMERASE REVERSE TRANSCRIPTASE REGULATOR

COMPOSITION FOR REGULATING EXPRESSION OF PROX1 OR EXPRESSION OF TELOMERASE REVERSE TRANSCRIPTASE COMPRISING ACTIVITY REGULATOR OR METHOD FOR SCREENING TELOMERASE REVERSE TRANSCRIPTASE REGULATOR

机译:调节包含活性调节剂的prox1表达或端粒酶逆转录酶表达的组合物或筛选端粒酶逆转录酶调节剂的方法

摘要

In the present specification, on the basis of the correlation between prospero homeobox protein 1 (PROX1) and telomerase reverse transcriptase (TERT), a composition for regulating expression of TERT, a method for screening a TERT expression regulator, a composition for diagnosing a TERT expression status, a diagnostic kit, a method for providing information for diagnosis, or a method for providing information for cancer diagnosis are disclosed. Specifically, in one aspect, the PROX1 of the present disclosure may bind to a TERT promoter, in particular a mutant TERT promoter in which base substitution occurs at the -124 or -146 bp position to regulate the expression of TERT, and the expression of TERT in non-hepatitis B virus-associated liver cancer can be inhibited specifically among liver cancers. Accordingly, the present disclosure may be utilized in various biomedical fields including compositions for regulating the expression of TERT, compositions for preventing, ameliorating or treating hepatitis B virus-associated liver cancer, and the like.
机译:在本说明书中,基于prospero同源盒蛋白1(PROX1)和端粒酶逆转录酶(TERT)之间的相关性,用于调节TERT表达的组合物,用于筛选TERT表达调节剂的方法,用于诊断TERT的组合物。公开了表达状态,诊断试剂盒,用于提供诊断信息的方法或用于提供癌症诊断信息的方法。具体而言,一方面,本公开的PROX1可以结合TERT启动子,特别是突变的TERT启动子,其中碱基取代发生在-124或-146bp位置以调节TERT的表达,以及与非乙型肝炎病毒相关的肝癌中的TERT可以在肝癌中被特异性抑制。因此,本公开可用于各种生物医学领域,包括用于调节TERT表达的组合物,用于预防,改善或治疗与乙型肝炎病毒相关的肝癌的组合物等。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号